Pharmaceutical PV DIV - FSB

Active Indefinite Delivery Contract Awarded Last action

Contract number
SPE2DR25D9317
Awardee
Awarding agency
Task orders
40 $200,843 obligated

Award facts

Opportunity
Combined order value
$200,843 Current and potential, with all options
Last date to order 82% complete
IDV ceiling 4% used
$4,999,999.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The federal contract IDV award SPE2DR25D9317 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 issued by the Defense Logistics Agency (DLA) to the woman-owned small business DMS Pharmaceutical Group Inc. The IDC has an ultimate completion date of December 31, 2026 and enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This supports the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The original pre-solicitation opportunity BAE3E46B4E4C421385F0D20AAF2C4525 outlines DLA's plan to establish a Pharmaceutical Prime Vendor Global Program Generation V contract to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The estimated total value of this multi-award contract is $30.3 billion, with at least three different contractors to be selected across four geographic regions. The solicitation is expected to be issued in March 2024 and remain open for 45 days, using a Lowest Price Technically Acceptable (LPTA) evaluation criteria.

Task orders

Task order Ordering agency Obligated Awarded
Xolair 300 MG/2 ML syringe 2ML SPE2DR26FSKJ4 Defense Logistics Agency $9,522
Xolair 300 MG/2 ML autoinject 2ML SPE2DR26FSKJ3 Defense Logistics Agency $5,242
Lurasidone HCL 120 MG tablet 30S SPE2DR26FSKJ2 Defense Logistics Agency $50
Mirena 52 MG systems SPE2DR26FSKJ1 Defense Logistics Agency $6,570
Iosat 130 MG tablet 14S SPE2DR26FSKJ0 Defense Logistics Agency $4,596
Iosat 130 MG tablet 14S SPE2DR26FSKH9 Defense Logistics Agency $81
Xolair 300 MG/2 ML syringe 2ML SPE2DR26FSKH7 Defense Logistics Agency $3,779
Xolair 300 MG/2 ML syringe 2ML SPE2DR26FSKH8 Defense Logistics Agency $7,557
Lurasidone HCL 120 MG tablet 30S SPE2DR26FSKH6 Defense Logistics Agency $50
Xolair 300 MG/2 ML syringe 2ML SPE2DR26FSKH5 Defense Logistics Agency $1,889
Mirena 52 MG systems SPE2DR26FSKH4 Defense Logistics Agency $5,475
Xolair 300 MG/2 ML autoinject 2ML SPE2DR26FSKH1 Defense Logistics Agency $10,485
Nexplanon 68 MG implants SPE2DR26FSKH2 Defense Logistics Agency $10,058
Xolair 150 MG/ML syringeml SPE2DR26FSKH0 Defense Logistics Agency $4,738
Fasenra pen 30 MG/mlml SPE2DR26FSKG9 Defense Logistics Agency $2,195
Nexplanon 68 MG implants SPE2DR26FSKG8 Defense Logistics Agency $10,058
Xolair 300 MG/2 ML autoinject 2ML SPE2DR26FSKG7 Defense Logistics Agency $5,242
Mirena 52 MG systems SPE2DR26FSKG6 Defense Logistics Agency $3,285
Xolair 150 MG/ML autoinjectorml SPE2DR26FSKG5 Defense Logistics Agency $2,621
Xolair 150 MG/ML syringeml SPE2DR26FSKG4 Defense Logistics Agency $3,158
Xolair 300 MG/2 ML syringe 2ML SPE2DR26FSKG3 Defense Logistics Agency $3,779
Xolair 300 MG/2 ML autoinject 2ML SPE2DR26FSKG2 Defense Logistics Agency $13,980
Xtandi 40 MG tablet 120S SPE2DR26FSKG1 Defense Logistics Agency $8,844
Xolair 150 MG/ML syringeml SPE2DR26FSKG0 Defense Logistics Agency $3,158
Acetaminophen 500 MG caplet 1000S SPE2DR26FSKF8 Defense Logistics Agency $30
Xolair 300 MG/2 ML syringe 2ML SPE2DR26FSKF9 Defense Logistics Agency $11,392
Kyleena 19.5 MG systems SPE2DR26FSKF7 Defense Logistics Agency $6,566
Kyleena 19.5 MG systems SPE2DR26FSKF5 Defense Logistics Agency $657
Easivent mask-mediums SPE2DR26FSKF6 Defense Logistics Agency $959
Xolair 300 MG/2 ML syringe 2ML SPE2DR26FSKF3 Defense Logistics Agency $11,336
Xolair 300 MG/2 ML autoinject 2ML SPE2DR26FSKF4 Defense Logistics Agency $10,485
Mirena 52 MG systems SPE2DR26FSKF2 Defense Logistics Agency $4,783
Easivent mask-mediums SPE2DR26FSKF1 Defense Logistics Agency $959
Diclofenac sodium 1% GEL 100GM SPE2DR26FSKF0 Defense Logistics Agency $140
Diclofenac sodium 1% GEL 100GM SPE2DR26FSKE9 Defense Logistics Agency $70
Xolair 300 MG/2 ML syringe 2ML SPE2DR26FSKE8 Defense Logistics Agency $11,392
Xolair 150 MG/ML autoinjectorml SPE2DR26FSKE7 Defense Logistics Agency $5,242
Xolair 150 MG/ML syringeml SPE2DR26FSKE6 Defense Logistics Agency $2,369
Nexplanon 68 MG implants SPE2DR26FSKE5 Defense Logistics Agency $5,683
Xolair 150 MG/ML syringeml SPE2DR26FSKE4 Defense Logistics Agency $2,369
Show all 40

Quick answers

Who was awarded contract SPE2DR25D9317?

SPE2DR25D9317 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.

How much is contract SPE2DR25D9317 worth?

Orders under SPE2DR25D9317 have obligated $200,843. SPE2DR25D9317's own ceiling is $4,999,999.

How many orders have been placed under contract SPE2DR25D9317?

40 orders have been placed under SPE2DR25D9317, the latest on June 24, 2026.

Who can order from contract SPE2DR25D9317?

SPE2DR25D9317 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract SPE2DR25D9317 competed?

The extent of competition for SPE2DR25D9317 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login